Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.22.2
Condensed Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Total revenue $ 6,552 $ 1,363,037 $ 52,583 $ 2,770,202
Revenue from Contract with Customer, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Costs and expenses:        
Research and development $ 2,982,183 $ 2,382,433 $ 5,999,174 $ 4,814,293
Selling, general and administrative 1,664,308 1,608,972 3,333,944 3,209,548
Total costs and expenses 4,646,491 3,991,405 9,333,118 8,023,841
Loss from operations (4,639,939) (2,628,368) (9,280,535) (5,253,639)
Interest expense (7,811) (5) (19,608)
Net loss $ (4,639,939) $ (2,636,179) $ (9,280,540) $ (5,273,247)
Net loss per share - basic $ (0.18) $ (0.22) $ (0.37) $ (0.47)
Net loss per share - diluted $ (0.18) $ (0.22) $ (0.37) $ (0.47)
Weighted average number of common share basic 25,227,051 12,241,935 25,216,312 11,153,986
Weighted Average Number of Shares Outstanding, Diluted 25,227,051 12,241,935 25,216,312 11,153,986